4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-22-054563
Chief Financial Officer sold 3,500 shares at $15.16 ($53,060)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jeanmonod Patrik Chief Financial Officer | 2022-10-24 | Sale | −3,500 | $15.16 | $53,060 | 85,563 | D |
| Open-market sales · 3,500 sh · avg $15.16 · $53,060 | |||||||
Loading xslF345X03/doc4.xml…